Pathogenicity and Virulence
Pathogenicity is specifically the characteristic or state of having the capacity to cause illness, whereas virulence is the ability of an organism to cause disease, or the level of pathogenicity within a group or species.Virulence factors are substances generated by microorganisms that cause illness. Toxins, surface coatings that prevent phagocytosis, and surface receptors that bind to host cells are a few examples.
In addition, Salmonella protein SopE, which functions as a GEF and activates the GTPase to produce additional GTP, is one example of a bacterial virulence factor that behaves like a eukaryotic protein. Nothing is changed, but the usual cellular internalisation process is overdriven, which makes it simpler for the bacteria to infiltrate a host cell.
Related Conference of Pathogenicity and Virulence
June 16-17, 2025
5th International Conference on Microbiology and Infectious Diseases
Amsterdam, Netherlands
September 22-23, 2025
11th International Conference on Infectious and Rare Diseases
Vancouver, Canada
October 06-07, 2025
13th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Las Vegas, USA
October 30-31, 2025
20th World Conference on Infectious Diseases, Prevention and Control
Paris, France
December 11-12, 2025
8th Annual Congress on Bacterial, Viral and Infectious Diseases
Prague, Czech Republic
Pathogenicity and Virulence Conference Speakers
Recommended Sessions
- Advanced Research in Microbiology
- Advances in Biomaterials
- Agricultural Microbiology
- Antimicrobial Agents and Resistance
- Aquatic Microbiology
- Biodegradation
- Bioremediation
- Biotechnology and Synthetic Biology
- Cell Biology
- Clinical Microbiology
- Environmental Microbiology
- Immunology
- Infectious agents and Diseases
- Microbial Genetics and Ecology
- Microbiology
- Microbiomes
- Molecular Biology
- Mycology
- Pathogenicity and Virulence
- Public Health Microbiology
- Recombinant DNA Technology
- Vaccines and Immunizations
- Viral Replication Dynamics and Antiviral Treatment
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- Advancement in the Diagnosis of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Alcohol and Drug Use - STD-HIV AIDS-2025 (USA)
- Antibiotics and Anti-viral - Euro Infectious Diseases 2025 (Netherlands)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2025 (UK)
- Bacterial Diseases - Euro Infectious Diseases 2025 (Netherlands)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2025 (UK)
- Biomarkers for Rare Disease Diagnosis and Treatment - Rare Diseases Congress 2025 (Netherlands)
- Biomedical Research - Rare Diseases Congress 2025 (Netherlands)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2025 (UK)
- Causes and Symptoms of Infections - Infection Prevention 2025 (UK)
- Challenges of Living with a Rare Disease - Rare Diseases Congress 2025 (Netherlands)
- Clinical Case Reports and Case Studies - Rare Diseases Congress 2025 (Netherlands)
- Clinical Research and Case Reports - STD-HIV AIDS-2025 (USA)
- Clinical Research on Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Co-infections Associated with STDs - STD-HIV AIDS-2025 (USA)
- Covid_19 Infections - Infection Prevention 2025 (UK)
- Dermatological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Diagnosis and Treatment - STD-HIV AIDS-2025 (USA)
- Diagnosis of infectious Diseases - Infection Prevention 2025 (UK)
- Different Types of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Drug Discovery for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Emerging and Re-Emerging Infections - Infection Prevention 2025 (UK)
- Emerging Technologies in Rare Disease Research - Rare Diseases Congress 2025 (Netherlands)
- Epidemiology - Infection Prevention 2025 (UK)
- Functional Genomics and Gene Therapy for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Fungal Infections - Euro Infectious Diseases 2025 (Netherlands)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2025 (UK)
- Genetic Testing and Counselling of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Global Trends in Emerging Infections - Infection Prevention 2025 (UK)
- Health Economics and Market Access for Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Hepatitis Prevention - Infection Prevention 2025 (UK)
- HIV and Women's Health Issues - STD-HIV AIDS-2025 (USA)
- Immunizations and Vaccination - Infection Prevention 2025 (UK)
- Infection Control in Critical Care - Infection Prevention 2025 (UK)
- Infection Control Procedures - Infection Prevention 2025 (UK)
- Infection Prevention and Control - Euro Infectious Diseases 2025 (Netherlands)
- Infection Prevention and Control - Infection Prevention 2025 (UK)
- Infectious Disease - Euro Infectious Diseases 2025 (Netherlands)
- Infectious Diseases and Immune Deficiencies - Rare Diseases Congress 2025 (Netherlands)
- Introduction and Causes of New Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Neuro Infections - Infection Prevention 2025 (UK)
- Neurological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Nosocomial Infections and Control - Infection Prevention 2025 (UK)
- Ophthalmological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Orphan Drugs Potentiality - Rare Diseases Congress 2025 (Netherlands)
- Paediatric Infectious Diseases - Euro Infectious Diseases 2025 (Netherlands)
- Parasitic Infections - Euro Infectious Diseases 2025 (Netherlands)
- Pediatric HIV - STD-HIV AIDS-2025 (USA)
- Plants Diseases and Infection Control - Infection Prevention 2025 (UK)
- Preventive Measures - Euro Infectious Diseases 2025 (Netherlands)
- Public Health - Euro Infectious Diseases 2025 (Netherlands)
- Public Health - STD-HIV AIDS-2025 (USA)
- Rare Autoimmune Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Bone Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Cancer - Rare Diseases Congress 2025 (Netherlands)
- Rare Diseases and Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Rare Diseases of the Heart and Vessels - Rare Diseases Congress 2025 (Netherlands)
- Rare Neurological Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Nutritional and Metabolic Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Paediatric Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Skin Diseases - Rare Diseases Congress 2025 (Netherlands)
- Recent Advancements - STD-HIV AIDS-2025 (USA)
- Regulatory Considerations for Developing Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2025 (UK)
- Respiratory tract infections - Euro Infectious Diseases 2025 (Netherlands)
- Sexual Health - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases - STD-HIV AIDS-2025 (USA)
- Testing and Health Monitoring - STD-HIV AIDS-2025 (USA)
- Transmission and Prevention - STD-HIV AIDS-2025 (USA)
- Treatment and Advanced Therapies for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Tropical diseases - Euro Infectious Diseases 2025 (Netherlands)
- Urinary Tract Infection - Euro Infectious Diseases 2025 (Netherlands)
- Vaccines - Euro Infectious Diseases 2025 (Netherlands)
- Vaccines and People with HIV - STD-HIV AIDS-2025 (USA)
- Vaccines and Vaccination for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Viral Infections - Euro Infectious Diseases 2025 (Netherlands)
- Viral Infections and Recent Advancements - Infection Prevention 2025 (UK)